Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency Pharmaceutical Investing
BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China Pharmaceutical Investing
Mesoblast Operational Highlights and Financial Results for the Half-Year Ended December 31, 2017 Genetics Investing
Supernus Announces Record Full Year 2017 Financial Results, Exceeding Operating Earnings Guidance Pharmaceutical Investing
GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2017 Financial Results Biotech Investing
Melinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE Pharmaceutical Investing
MacroGenics Provides Update on Corporate Progress and 2017 Financial Results Pharmaceutical Investing
MannKind Corporation Reports 2017 Fourth Quarter and Full Year Financial Results Pharmaceutical Investing
Achaogen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
